Charged Alpha Stock Encyclopedia

Northrop Grumman (NOC) Q2 2026 — Northrop Grumman (NOC), the wide-moat U.S. defense prime and sole B-21 stealth-bomber builder, reported Q2 2026 that looked soft on the surface but was solid underneath. GAAP diluted EPS of $7.68 (net earnings −7% YoY, operating income −23%) beat the ~$6.84 estimate — but the YoY 'decline' is a mirage: a year ago NOC booked a $1.04/share training-services divestiture gain, so ex-gain EPS actually GREW ~8%, and the beat itself came almost entirely from a one-time 6.3% tax rate (an IRS settlement, ~$0.80/share). Sales rose 5% to $10.88B (all four segments up), net awards hit $20.0B (~1.8x book-to-bill), and backlog set a company record of $104.7B (+9%). Operating cash flow +47%, adjusted free cash flow +54% to $978M. Management RAISED FY26 sales ($43.75–44.25B) and MTM-adjusted EPS ($28.60–29.10) guidance and reaffirmed adjusted FCF of $3.1–3.5B. The blemish: recurring fixed-price charges — $91M on the GEM 63XL rocket motor and $68M on the SiAW missile — pushed Defense Systems margin to 7.5% (from 12.7%). At ~$524, down ~32% from its $774 high and near its 52-week low, NOC trades ~18x forward earnings. Our owner-earnings DCF lands fair value near $610 (~16% upside). Our call: BUY, 4/5.

Northrop Grumman is one of the five great American defense primes — the sole prime on the B-21 Raider stealth bomber and on Sentinel, the ground-based nuclear missile, with 85%+ of revenue from the U.S. and allied governments on multi-year, near-uncancelable programs. Q2 2026 looked soft on the surface: net earnings fell 7% and operating income dropped 23%. But that's an optical illusion — a year-ago quarter that included a $1.04/share gain from selling the training-services business. Strip it out and EPS actually grew ~8%. Diluted EPS of $7.68 beat the ~$6.84 estimate, though (in full honesty) that beat came almost entirely from a one-time 6.3% tax rate (an IRS settlement worth ~$0.80/share). The genuine signal was orders and cash: sales +5% to $10.88B across all four segments, net awards of $20.0B (~1.8x book-to-bill), a record $104.7B backlog (+9%, ~2.4x sales), operating cash flow +47%, and adjusted free cash flow +54% to $978M. Management RAISED FY26 sales and MTM-adjusted EPS guidance ($43.75–44.25B; $28.60–29.10) and reaffirmed adjusted FCF of $3.1–3.5B. The real blemish — and the reason the stock is cheap — is recurring fixed-price program charges: $91M on the GEM 63XL rocket motor and $68M on the SiAW missile this quarter (a $477M B-21 loss provision a year ago), pushing Defense Systems margin to 7.5%. But the big programs behaved: B-21 ramped with no new charge and Sentinel earned an incentive. At ~$524 — down ~32% from a $774 high and near its 52-week low — NOC trades ~18x forward earnings, cheap for a franchise this entrenched. Owner earnings ≈ adjusted FCF (~$3.3B, set to inflect toward the mid-$4Bs as B-21/Sentinel capex rolls off); our DCF (steady 8%→4% = $432–$612; inflection 13%→6% = $591–$876) lands fair value near $610, ~16% above the price. Our call: BUY, 4/5 — a beaten-down defense champion at a discount, sized for the fixed-price-charge risk. We ALIGN with the Street's Buy (20 of 35), and our ~$610 fair value sits right in the freshest July target cluster ($580–$640). Not financial advice.

THE CALL: BUY (4/5, A BEATEN-DOWN DEFENSE CHAMPION AT A DISCOUNT — RECORD BACKLOG, CHEAP MULTIPLE, WITH FIXED-PRICE-CHARGE RISK TO RESPECT) — base-case value ~$610 vs ~$524 today.

What to watch: hard evidence the free-cash-flow inflection is real — elevated B-21/Sentinel capital spending rolling off and adjusted FCF climbing from ~$3.3B toward the mid-$4B range, alongside a couple of clean quarters with no fresh EAC charges — which would re-rate the multiple toward the Street's higher targets and could push our conviction higher; the risk to respect is a cluster of new fixed-price charges (the GEM 63XL / SiAW pattern spreading to larger programs) or a prolonged government shutdown / continuing resolution that stalls awards and cash conversion

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Danaher Corporation (DHR) Q2 2026 — Danaher (DHR), the wide-moat life-sciences and diagnostics compounder, reported a solid Q2 2026: adjusted EPS of $1.94 beat the ~$1.84 estimate (+8% YoY) on revenue of $6.27B (+5.5%, core +3.0%). GAAP EPS jumped 60% to $1.23 (flattered by a prior-year impairment). Management RAISED full-year 2026 adjusted EPS guidance to $8.45–$8.60 (from $8.35–$8.55), helped by closing the ~$9.9B Masimo acquisition early (June 10). The key tell: bioprocessing orders grew mid-teens — the destocking that broke the stock is ending. Yet DHR (~$201, down ~1.3% on the print) slipped, because core growth is still just 3% and the deal added ~$8B of debt. After a de-rating from a $242 high to a $162 low, our owner-earnings DCF lands fair value near $205 — essentially the price. Our call: HOLD, 3/5 — a wonderful compounder, finally at a fair price.

Danaher is one of the great compounding machines in the market — a ~$142B maker of the picks-and-shovels of life science and diagnostics (about 75% recurring revenue), run by CEO Rainer Blair on the legendary Danaher Business System. Q2 2026 was a solid quarter: adjusted EPS of $1.94 beat the ~$1.84 estimate (+8% YoY), revenue rose 5.5% to $6.27B (core +3.0%), and GAAP EPS jumped 60% to $1.23 (flattered by a prior-year impairment). For the win, management RAISED full-year adjusted EPS guidance to $8.45–$8.60 (from $8.35–$8.55), helped by closing the ~$9.9B Masimo patient-monitoring acquisition early on June 10. The most important tell wasn't on the P&L: bioprocessing orders grew mid-teens, the clearest sign yet that the two-year destocking that broke this stock is ending, with Life Sciences posting its best quarter in years. So why did the stock slip? Because the recovery is still a promise — core growth is only 3% (Q3 guided +2–3%), the Masimo deal added ~$8B of debt (total ~$26.6B), and it dilutes margins near-term. After a brutal de-rating from a $242 high to a $162 low and back to ~$201, our owner-earnings DCF (base ~$5.5B FCF; steady 6%→4% = $134–$189, compounder 10%→5.5% = $182–$277) lands fair value near $205 — essentially today's price. A wonderful business, finally fair, but not yet a bargain. Our call: HOLD, 3/5. We're a touch more cautious than the Street's bullish ~$242 (Buy), and we'd add aggressively on the dips this volatile stock keeps handing out (mid-$160s in May, ~$181 in June). Watch bioprocessing orders. Not financial advice.

THE CALL: HOLD (3/5, A WONDERFUL COMPOUNDER, FINALLY AT A FAIR PRICE — A BEAT-AND-RAISE WITH NO MARGIN OF SAFETY YET) — base-case value ~$205 vs ~$201 today.

What to watch: evidence the bioprocessing recovery is real in the numbers, not just orders — two or three quarters of accelerating core revenue growth as bioprocessing converts and Masimo contributes — which would justify the Street's higher target and prompt an upgrade; the risk to respect is a stalled recovery with core growth stuck near 3% while ~$8B of Masimo debt and integration weigh on returns, which at a fair-not-cheap price would leave the stock treading water

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Novartis AG (NVS) Q2 2026 — Novartis (NVS), the ~$285B Swiss pharma giant, reported Q2 2026 before the open on July 21: net sales of $14.4B rose +1% in constant currency (+3% USD) — a RETURN TO GROWTH after Q1's -5% cc decline — and core operating income of $5.94B beat the ~$5.3B consensus at a 41.2% margin. Core EPS of $2.41 beat the $2.17 estimate. But reported (IFRS) EPS fell -17% to $1.71, net income dropped -19% on higher taxes and interest, and free cash flow slipped -12% to $5.6B as net debt DOUBLED to $39.4B on M&A (Avidity, Myricx). Entresto fell -50% to $1.18B as US generics launched, while Kisqali (+43%), Kesimpta (+32%), Scemblix (+89%), Pluvicto (+43%) and Leqvio (+59%) more than filled the hole. FY2026 guidance reaffirmed (net sales grow LSD, core op income decline LSD). The ADR fell ~2.7% to ~$149.56 on the print.

Novartis (NVS) is one of the two or three largest drugmakers on earth — a ~$285B Swiss pure-play innovative-medicines company (Aa3/AA-) led by Vas Narasimhan. Q2 2026 was, on the surface, a strong quarter: net sales of $14.4B returned to growth (+1% cc, +3% USD), core operating income of $5.94B beat the ~$5.3B Street estimate at a superb 41.2% margin, core EPS of $2.41 beat $2.17 — and the crown-jewel drug Kisqali won a surprise 6-month FDA pediatric exclusivity. The growth engine (Kisqali +43%, Kesimpta +32%, Scemblix +89%, Pluvicto +43%, Leqvio +59%, Fabhalta +88%) more than absorbed the Entresto patent cliff (-50% to $1.18B on US generics; EU LOE in November). Yet the ADR FELL ~3% on the print. Why? Underneath the polished 'core' numbers, reported IFRS EPS fell -17% to $1.71, net income dropped -19%, and free cash flow slipped -12% — because net debt DOUBLED from $21.9B to $39.4B in six months funding a $15.3B M&A spree. Management reaffirmed a trough-year guide (core operating income to DECLINE low-single-digits in 2026), and both Goldman and Jefferies say the premium multiple now hinges on second-half pipeline readouts. Our owner-earnings DCF (base ~$15.5B FCF, +2%/+5% growth, 7-8-9% discount, less $39.4B net debt, ~1.91B shares) centers near $128 vs the ~$150 price — about 15% below. Our call: HOLD, 3/5. Quality is not the question; the price is. We ALIGN with the Street's Hold (avg target ~$155, ~+4%) but are a shade more cautious. We'd own this fortress cheaper — under ~$120 — not here. Not financial advice.

THE CALL: HOLD (3/5, A FORTRESS FRANCHISE THAT RETURNED TO GROWTH — BUT AT ~17x, WITH CORE PROFIT STILL FALLING AND NET DEBT DOUBLED, THE PRICE ALREADY PAYS FOR THE PIPELINE) — base-case value ~$128 vs ~$149.56 today.

What to watch: clean wins in the second-half 2026 pipeline readouts (Goldman's bar: at least 2 of 3 major late-stage trials) or a return to core operating-income GROWTH in 2027 would justify the premium multiple and prompt an upgrade; the risks to respect are a guidance cut, a pipeline miss, or generic erosion (Entresto EU LOE in November) out-running the launch brands — watch the growth drivers and readouts each quarter

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Calix (CALX) Q2 2026 — Calix (CALX), the broadband-platform company, reported a strong Q2 2026: RECORD revenue of $293.3M (+21% YoY, +5% sequential), record software & services of $50.5M (+16% YoY), and a headline EPS of $0.47 that beat the ~$0.41 estimate — but be precise: that $0.47 is NON-GAAP; GAAP diluted EPS was $0.26, with the $0.21 gap being stock-based comp. The company added 14 new service-provider customers, tripled Calix One contracts, grew backlog (RPO) to a record $386.4M (+11% YoY), generated $11.9M of free cash flow, ended debt-free with $194M cash & investments, and bought back $69.4M of stock ($240M across H1). Q3 guidance: revenue $301-307M, but non-GAAP gross margin guided DOWN to ~52% midpoint on spiking memory-chip costs. The stock (~$38, down ~2% on the day) has fallen ~46% from its ~$71 autumn-2025 high and sits near its 52-week low. Our scenario DCF blends to a prob-weighted ~$45 fair value (bear ~$33 / bull ~$56) vs ~$38 today — ~18% upside. Our call: BUY, 3/5 (accumulate) — a de-rated, debt-free grower, but the beat leans on non-GAAP and margins are pinched near-term. More cautious than the Street's Buy / ~$63 average target.

Calix (NYSE: CALX) is the 'arms dealer' for fiber internet — it sells the appliances (hardware), cloud software, and managed services that 1,200+ service providers use to wire homes, businesses, and towns with broadband, all now unified on its AI-native Calix One platform. Q2 2026 was the tension the whole episode turns on: the company reported RECORD revenue of $293.3M (+21% YoY, +5% sequential), a record software & services line of $50.5M (+16% YoY), record backlog (RPO) of $386.4M (+11% YoY), 14 new customers, and a tripling of Calix One contracts — yet the stock sits near a 52-week low, down ~46% from its ~$71 autumn-2025 high. The headline you'll see everywhere is a $0.47 EPS 'beat' vs ~$0.41 — but we insist on precision: that $0.47 is NON-GAAP. On a GAAP basis, Calix earned $0.26 a share; the $0.21 difference is almost entirely stock-based compensation ($16.7M, ~6% of revenue) added back. That SBC is a real cost, though aggressive buybacks ($240M in H1, $94M still authorized) are offsetting the dilution and shrinking the share count. The bull case: a debt-free company (only $194M cash and no borrowings) growing 21%, with a genuine software mix-shift, trading at only ~16x forward non-GAAP EPS and ~1.9x forward sales — the CHEAPEST networking name on revenue (vs ADTRAN ~1.0x but unprofitable, Harmonic ~2.6x, Cisco ~7.5x, Ciena ~10x). The bear case: it's still ~83% hardware, GAAP profits are thin, and gross margin is actively compressing — Q3 non-GAAP gross margin is guided down ~280bps to ~52% midpoint as AI-datacenter demand spikes memory-chip costs. Add customer concentration (one customer = 12% of revenue) and lumpy service-provider/BEAD-funding timing. The swing factor is margin expansion: management targets ~15% growth with operating margin climbing toward 20% (from the low teens today). Our owner-earnings / path-to-profitability DCF discounts a base case (Calix hits its ~15% model, margins drift up) and a bull case (they reach the 20% operating-margin target) at 8/9/10%; at our 9% base rate that's ~$45 base and ~$56 bull, with a ~$33 bear if margins stall. Probability-weighted (~45% base / 30% bear / 25% bull) lands near ~$45 vs ~$38 today — roughly 18% upside, cushioned by that fortress balance sheet. Our call: BUY, 3/5 — a measured 'accumulate,' best near the 52-week low ($34-36), not table-pounding, because the reported profitability leans on non-GAAP and near-term margins are heading the wrong way. We're notably more cautious than Wall Street's Buy consensus (~15 buy / 5 hold / 1 sell) and ~$63 average target (range $52-85), which looks like it's lagging the stock down. Watch the gross-margin line above all else. Not financial advice.

THE CALL: BUY (3/5, DE-RATED, DEBT-FREE GROWTH AT A 52-WEEK LOW — BUT THE $0.47 'BEAT' IS NON-GAAP (GAAP EPS $0.26) AND GROSS MARGINS ARE COMPRESSING NEAR-TERM; A MEASURED 'ACCUMULATE,' NOT TABLE-POUNDING) — base-case value ~$45 vs ~$38 today.

What to watch: clear evidence the margin ramp is inflecting — gross margin recovering past the near-term memory-cost hump (Q3 guided to ~52%), non-GAAP operating margin visibly marching toward the 20% target, and backlog (RPO) growth accelerating as agentic-AI 'Calix One' contracts convert — which would justify the ~$56 bull-case value and an upgrade toward 4/5; the risk to respect is the opposite: revenue growth fading below ~10%, gross margins stuck in the low-50s while memory costs persist, or stock-based comp staying elevated (~6% of revenue) while the buyback slows, in which case ~2x sales is no longer cheap and the ~$33 bear case (margins stall near today's low-teens operating margin) becomes the base case

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Steel Dynamics (STLD) Q2 2026 — Steel Dynamics (STLD), one of the largest U.S. electric-arc-furnace (EAF) steelmakers, reported a RECORD Q2 2026: net sales rose 33% to $6.1B, operating income jumped 83% to $700M, and diluted EPS surged 84% year-over-year to $3.69 — beating the company's own raised guidance of $3.51–$3.55 (even after a $16M non-cash impairment on relocating a planned aluminum site from Arizona to Columbus, Mississippi). Adjusted EBITDA was $921M on record steel shipments of 3.7M tons, as steel selling prices (ASP $1,298/ton, +$105 sequentially) outran ferrous scrap costs ($412/ton, +$16). The company generated $428M of operating cash flow, bought back $200M of stock (~1% of shares), and raised the dividend ~6% to $0.53/quarter. Yet the stock (~$230) sits ~20% BELOW its June 2026 high of $289, after nearly doubling off its 2025 low near $120. On honest mid-cycle math our blended fair value is ~$200 — below today's price. Our call: HOLD.

Steel Dynamics is one of the largest and best-run steel producers in the United States — a low-cost electric-arc-furnace (EAF) 'mini-mill' operator that melts recycled scrap rather than smelting iron ore, giving it a structural cost and carbon advantage over legacy blast-furnace mills. It runs ~12M tons of annual steel capacity across four segments — steel operations (the core engine), metals recycling, steel fabrication, and a brand-new aluminum flat-rolled business — and earns a best-in-class ~13% three-year after-tax return on invested capital. Q2 2026 was a genuine blowout: net sales +33% to $6.1B, operating income +83% to $700M, and diluted EPS +84% to $3.69, beating its own raised $3.51–$3.55 guidance. The beat was operational, not accounting: metal spreads widened as steel ASP rose $105/ton to $1,298 while scrap rose just $16 to $412, on record shipments of 3.7M tons, and the steel-fabrication backlog is up 45% YoY into 2027. Segment operating income: Steel $721M, Fabrication $85M, Metals Recycling $48M — and Aluminum a $33M startup loss (narrowing 48% sequentially) as the 650,000-ton Columbus, MS mill ramps toward automotive qualification by end-2026. So why only a HOLD? Because steel is deeply CYCLICAL: today's fat spreads and record earnings sit near a strong point in the cycle, and the stock has already nearly doubled off its 2025 low. Valuing a cyclical on mid-cycle (not peak) owner earnings — normalized FCF of ~$1.75–2.05B/yr, discounted at 8/9/10% and net of ~$3.6B net debt — our two-scenario DCF spans ~$147–$210 (mid-cycle) and ~$191–$272 (up-cycle), blending to ~$200 at 9%, with a ~$150 downside if the cycle rolls over. That's BELOW the ~$230 price: no margin of safety. At ~21x trailing earnings and ~11–12x EV/EBITDA, STLD is fairly valued versus fellow EAF leader Nucor — a premium operator at a premium-operator multiple, not a bargain, with a slim ~0.9% dividend. Our verdict: HOLD, 3/5. A company to admire and a price to wait on — we're more cautious than Wall Street's Buy consensus and ~$272 average target. Not financial advice.

THE CALL: HOLD (3/5, A GREAT COMPANY AT A CYCLICAL PRICE — RECORD QUARTER AND REAL ALUMINUM OPTIONALITY, BUT PEAK-ish EARNINGS AND NO MARGIN OF SAFETY AFTER A NEAR-DOUBLE OFF THE LOW) — base-case value ~$200 vs ~$230 today.

What to watch: Watch metal spreads (steel ASP vs. ferrous scrap cost) above all else — the single biggest driver of quarterly profit — plus the aluminum ramp (shipments, yields, and the path to sustained profitability into 2027). We'd turn more constructive on a pullback toward ~$185 or below (closer to mid-cycle earnings support), or on clear evidence the 650k-ton aluminum mill is reaching durable profitability while steel spreads hold — which would add a fourth earnings engine and justify a higher value. The risk to respect is the opposite: spreads compressing (scrap rising faster than steel prices) or a construction/industrial slowdown, in which case earnings and the multiple compress together and the stock heads toward the ~$150 downside case.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Ryanair Holdings (RYAAY) Q1 FY2027 — Ryanair Holdings (RYAAY), Europe's largest and most profitable airline, reported a rough fiscal Q1 2027 (quarter ended 30 June 2026): profit after tax fell 34% to €538M as ~20% of its jet fuel sat unhedged into the Iran-war oil spike and average fares fell 6%. Yet traffic still grew 6% to 61.3M passengers, revenue edged up 1% to €4.38B, operating costs rose 11% to €3.81B, and the balance sheet turned DEBT-FREE (€2.7B net cash) with a €750M buyback underway. The ADR fell ~6% on the print to ~$59 — near the low end of its 52-week range ($53–$74) — and trades at ~12x earnings and just ~6.4x EV/EBITDA: the cheapest multiple AND the highest net margin (~14%) of any major airline (vs DAL 5.8%, UAL 5.6%, LUV 2.8%, AAL 0.4%). Our owner-earnings DCF blends to ~$80 vs ~$59 today (~35% upside), with even the conservative case (~$71) above the current price. Our call: BUY, 4/5.

Ryanair is Europe's largest airline by passengers — around 216 million guests a year from 95 bases across 35 countries — and the most profitable major carrier in the world, built on a ruthless ultra-low-cost model: one aircraft type (the Boeing 737), high load factors, and the lowest cost per seat in Europe. Fiscal Q1 2027 (quarter ended 30 June 2026) looked ugly on the surface: profit after tax fell 34% to €538M and revenue rose just 1% to €4.38B. But almost the entire miss was fuel. About 20% of jet fuel was unhedged exactly as the Iran conflict and Strait-of-Hormuz fears spiked crude, and that unhedged slice roughly doubled year-on-year — a 'miss made in Tehran, not Dublin.' The same oil spike softened summer demand, pushing average fares down 6%, while operating costs jumped 11% to €3.81B. Underneath, though, the business is intact: traffic grew 6% to 61.3M passengers, load factors held, and the operation kept widening its cost lead. The balance sheet is a fortress — Ryanair repaid its final €1.2B bond in May 2026 to become DEBT-FREE, now sits on ~€2.7B of net cash, and is executing a €750M buyback, all while generating ~€1.8B of free cash flow after ~€1.9B of fleet-growth capex. The fuel shock is largely transitory: FY27 is 80% hedged at $67/bbl for the rest of the year, with ~15% of FY28 already locked near $85. Valuation is the real story: at ~$59 the ADR trades at ~12x earnings and ~6.4x EV/EBITDA — the CHEAPEST multiple of any major airline — yet earns a ~14% net margin, 2-to-5x every US peer (Delta 5.8%, United 5.6%, Southwest 2.8%, American 0.4%), and is the only one with net cash instead of net debt. Our owner-earnings DCF (normalized ~€1.9B, discounted at 8/9/10%, net cash added, converted to USD per ADR) spans a conservative 'fares stay soft' path (~$63–$83) and a base 'fares steady' path (~$77–$103); at 9% that's ~$71 conservative and ~$88 base, blending ~$80 vs ~$59 today — roughly 35% upside, with the pessimistic case still above the current price. Our call: BUY, 4/5. A best-in-class operator marked down on a transitory fuel shock, with a rare margin of safety — we stop short of 5/5 only because airline earnings are cyclical and fares could keep softening. We ALIGN with the Street's Moderate Buy and ~$78 average target. Not financial advice.

THE CALL: BUY (4/5, QUALITY ON SALE AFTER A TRANSITORY FUEL SHOCK — THE HIGHEST NET MARGIN AND CHEAPEST EV/EBITDA OF ANY MAJOR AIRLINE, DEBT-FREE WITH €2.7B NET CASH AND A €750M BUYBACK, WITH EVEN THE CONSERVATIVE CASE ABOVE TODAY'S PRICE) — base-case value ~$80 vs ~$58.91 today.

What to watch: an upgrade toward the base-case ~$88 fair value would come from fares stabilizing into H2 FY27 and FY28 while fuel stays near the $67/bbl hedge — confirming that Q1's fare and fuel hit was transitory and letting normalized earnings re-rate higher on a debt-free, buying-back balance sheet; the risk to respect is that fare deflation proves structural (Q2 pricing is already guided down low-to-mid single digits as European capacity returns) and/or a sustained fuel spike hits the ~20% unhedged book, on top of ATC disruptions and rising environmental taxes — in which case last year's profit was a cyclical peak, and the conservative ~$71 path (still near today's price) becomes the base case

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Domino's Pizza (DPZ) Q2 2026 — Domino's Pizza (DPZ), the largest pizza company in the world, reported a mixed Q2 2026: revenue rose 4.3% to $1.19B (a slight beat) and diluted EPS grew 6.8% to $4.07 (just shy of the ~$4.17 estimate), but U.S. same-store sales rose just +0.1% — the weakest in over a year — and international same-store sales turned NEGATIVE (-0.1%). The company added 209 net new stores (26 U.S., 183 international) to 22,531 worldwide, raised its dividend to $1.99/quarter, and bought back $156M of stock. The stock (~$329, +2.1% on the print) has fallen ~34% from its 2025 high near $496 and now trades at ~18x earnings — a discount to McDonald's, Yum, and Chipotle. The catch: with U.S. comps flat, international negative, and H1 free cash flow down 5.5%, the growth engine has stalled. Our owner-earnings DCF blends to ~$353 vs $329 — only a ~7% edge, and the soft case ($309) sits below today. Our call: HOLD.

Domino's Pizza is the world's largest pizza company — an asset-light franchise-and-royalty machine with 22,531 stores across 90+ markets, ~99% franchised, and over $20.6B of global retail sales. For years it was the premium growth name in fast food, trading at 28-30x earnings. Q2 2026 showed why that premium has evaporated: revenue rose 4.3% to $1.19B (a slight beat) and EPS grew 6.8% to $4.07 (a slight miss vs ~$4.17), but the growth engine stalled — U.S. same-store sales rose just +0.1% (weakest in over a year) and international same-store sales turned negative (-0.1%) for the first time in a long while. And the revenue 'beat' was low quality: 61% of revenue is the low-margin (~12%) supply-chain business (selling dough and ingredients to franchisees), while the high-margin U.S. franchise royalties that actually drive profit are tied to those flat same-store sales. CEO Russell Weiner leaned on ORDER-COUNT growth — but with orders up and sales dollars flat, the average ticket is soft: the classic signature of a value war, waged partly through thin-economics aggregators (Uber Eats, DoorDash). The bull case is real: ~$655M of trailing free cash flow, a just-raised dividend (~2.4% yield), aggressive buybacks ($1.23B still authorized), relentless unit growth, and — after a ~34% drop from its $496 high — a ~18-19x P/E that makes Domino's the CHEAPEST major QSR franchisor (vs MCD ~22x, YUM ~24x, CMG ~30x). But it runs on heavy leverage by design (4.3x, negative book equity), and H1 free cash flow actually declined 5.5%. Our owner-earnings DCF (levered FCF discounted at 8/9/10%) spans a wide range: a conservative 'comps stay soft' path lands near $309 at our 9% base rate, while a 'modest re-accel' path lands near $397. Blend them 50/50 and you get ~$353 vs ~$329 today — a real but thin ~7% edge, not a margin of safety, with the soft case BELOW the current price. That's a coin-flip that hinges entirely on whether same-store sales reaccelerate. Our call: HOLD, 3/5. An elite franchise, finally on sale, but with its growth engine stalled — cheap enough to respect, not cheap enough to chase. We're a touch more cautious than the Street's Buy consensus (28 buy / 23 hold / 1 sell) and ~$390 average target (which analysts were cutting into the print). Not financial advice.

THE CALL: HOLD (3/5, CHEAP FOR DOMINO'S, BUT THE GROWTH ENGINE STALLED — A REVENUE BEAT MASKING FLAT U.S. AND NEGATIVE INTERNATIONAL COMPS, WITH NO MARGIN OF SAFETY YET) — base-case value ~$353 vs ~$329 today.

What to watch: clear evidence the growth engine is restarting — U.S. same-store sales re-accelerating, international turning positive again, and order-count growth finally converting into same-store SALES dollars (not just traffic) — which would justify the base-case ~$397 fair value and prompt an upgrade; the risk to respect is comps staying flat or negative while third-party aggregator (Uber Eats/DoorDash) and value-deal mix keep pressuring the average ticket and margins, in which case ~18x earnings is not cheap enough and the conservative ~$309 value (below today's price) becomes the base case

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Insteel Industries (IIIN) Q3 FY2026 — Insteel Industries (NYSE: IIIN) reported Q3 FY2026 (quarter ended June 27, 2026) on July 16: net sales $197.7M, +9.9% YoY, driven by an 8.0% rise in average selling prices and a 1.7% increase in shipments (sequentially, ASPs +2.3% and shipments +11.9%); diluted EPS $0.46 versus $0.45 expected and $0.78 a year ago; net earnings $9.0M versus $15.2M. Gross profit fell to $20.1M from $30.8M and gross margin narrowed to 10.2% from 17.1%. SG&A fell 19.7% to $8.5M. The company ended the quarter debt-free with $22.9M of cash and a fully undrawn $100M revolver, repurchased 75,000 shares for $1.9M, and cut FY2026 capital expenditure guidance to about $15.0M from about $20.0M. Shares closed at $31.00 on July 17, up 3.3%.

Insteel Industries is the largest U.S. manufacturer of steel wire reinforcing products for concrete construction — prestressed concrete strand and welded wire reinforcement, including engineered structural mesh — sold primarily into nonresidential construction from eleven domestic plants headquartered in Mount Airy, North Carolina. It is a converter: it buys hot-rolled carbon steel wire rod and sells reinforcement, so the entire business is the spread between the two. In the June quarter that spread collapsed. Insteel pushed selling prices up 8.0% and still watched gross margin fall from 17.1% to 10.2%, because cost of sales rose $28.4M against just $17.8M of additional revenue. This episode works through the tariff mechanics behind that cost, the $33.1M wire-rod sensitivity buried in the 10-Q, the data-center demand nobody prices as AI exposure, and what a genuinely cyclical business is worth on mid-cycle rather than trough earnings.

THE CALL: HOLD (3/5, A GOOD OPERATOR AT A FAIR PRICE — THE MARGIN RECOVERY IS REAL, BUT AT $31 YOU ARE ALREADY PAYING FOR IT) — base-case value ~$28.60 vs ~$31.00 today.

What to watch: Gross margin climbing back above 13% for a quarter would confirm that pricing has finally caught the cost curve and would push our fair value toward $33; a fall back under about $25 — where the stock traded in April and where management itself was repurchasing shares at roughly $26 — is where the bear case is already priced and where we would become buyers. What breaks the thesis: hot-rolled carbon steel wire rod climbing further (a 10% rise cuts pre-tax earnings by $33.1M, more than the entire nine-month pre-tax result of $28.1M), or the data-center schedule delays management describes as timing turning into outright cancellations. Watch gross margin and the inventory line; both move before EPS does.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Wipro (WIT) Q1 FY2027 — Wipro (NYSE: WIT) reported Q1 FY2027 (quarter ended June 30, 2026) on July 16: gross revenue Rs 244.8 billion ($2,585.9M), +1.0% QoQ and +10.6% YoY in rupees; IT services segment revenue $2,614.5M, -1.4% QoQ and +1.0% YoY, or -1.2% QoQ and +0.9% YoY in constant currency. Net income Rs 33.6 billion ($354.6M), -4.7% QoQ and +0.6% YoY; EPS Rs 3.20 ($0.03), exactly in line with the $0.03 consensus. IT services operating margin fell to 16.0%, down 1.3pp QoQ and 1.2pp YoY (Indian coverage called the consolidated figure a 15-quarter low). Total bookings $3,370M, -2.4% QoQ in constant currency, while large deal bookings (>=$30M TCV) rose 12.9% QoQ to $1,626M across 13 deals — so large deals are now 48% of all bookings while the smaller discretionary book shrinks. Voluntary attrition 13.9% on a trailing-12-month basis. Cash conversion stayed excellent: operating cash flow Rs 32.9 billion ($348M) at 98.0% of net income, free cash flow Rs 29,617M at 88.2% of net income. Balance sheet at June 30, 2026: cash Rs 88,444M ($934M) plus investments Rs 336,462M ($3,554M) against Rs 177,649M ($1,877M) of borrowings and zero long-term debt — roughly $2.6B net cash; total equity Rs 776,769M ($8,205M). Interim dividend of Rs 2 ($0.02) per share/ADS declared; management says more than $3B was returned to shareholders over the past year. Guidance for the September quarter: IT services revenue $2,574M-$2,627M, or -1.5% to +0.5% sequentially in constant currency — a negative midpoint. The stock trades near $1.86, just above a 52-week low of $1.80 and ~40% below the $3.09 high, at ~14x earnings with a 6.25% trailing dividend yield; JPMorgan cut it to Underweight with a $1.70 target on July 1, citing AI-driven pricing pressure. Our owner-earnings DCF (base ~$1.5B FCF, 0% vs +4% growth, 9/10/11% discount, 2% terminal, plus net cash) lands ~$2.08 probability-weighted, range $1.74-$2.52. Wall Street ADR consensus: Sell (0 buy / 2 hold / 5 sell), average target ~$2.00. Our call: HOLD, 3/5 — cheap and well-financed, but nothing has inflected.

Wipro is one of India's largest IT-services companies, running applications, cloud, infrastructure and back-office operations for large Western corporations with more than 230,000 employees and business partners across 65 countries. Its Q1 FY2027 print was reported across Indian media as revenue up 10.6% year over year - and that number is a currency mirage. Wipro's own release states constant-currency IT services revenue grew just 0.9% YoY, and fell 1.2% sequentially; the entire gap is the rupee's decline against the dollar. If you own the New York ADS you are paid in dollars, and your growth was 1.0%. EPS of $0.03 (Rs 3.20) landed exactly in line on an already-lowered bar, and net income rose 0.6%. The margin is where the damage shows: IT services operating margin fell to 16.0%, down 1.3 points sequentially and 1.2 points YoY, with CFO Aparna Iyer conceding investments 'may create some near-term margin volatility.' A second under-covered signal sits in the order book: total bookings fell 2.4% QoQ in constant currency to $3,370M while large deals rose 12.9% to $1,626M across 13 signings - so large, low-margin vendor-consolidation and cost-takeout work is now 48% of all bookings while higher-margin discretionary work disappears. The offsetting case is real: operating cash flow was 98% of net income, free cash flow 88%, the balance sheet holds roughly $2.6B of net cash with zero long-term debt, more than $3B was returned to shareholders over the past year, and the shares yield 6.25% at ~14x earnings, already ~40% below last July's high and barely above a 52-week low. But September-quarter guidance of -1.5% to +0.5% sequential constant-currency growth has a negative midpoint, and JPMorgan cut the stock to Underweight at $1.70 on AI-driven pricing pressure. The structural question - whether AI compresses a labor-arbitrage model billed by the person - is genuinely unresolved. Our owner-earnings DCF lands ~$2.08 versus ~$1.86 today, but the conservative corner at an 11% discount rate is $1.74, below the current price. Our call: HOLD, 3/5 - you are paid 6.25% to wait for an answer nobody has yet. Not financial advice.

THE CALL: HOLD (3/5, CHEAP AND WELL-FINANCED, BUT NOTHING HAS INFLECTED — PAID 6.25% TO WAIT ON AN UNRESOLVED AI QUESTION) — base-case value ~$2.08 vs ~$1.86 today.

What to watch: The IT services operating margin climbing back above 17%, or a single quarter of positive constant-currency SEQUENTIAL growth, would say the squeeze is ending and push us more constructive; a drop under about $1.75 - the conservative corner of our own DCF - would create a genuine margin of safety and a stronger buy case. The thesis breaks the other way if total bookings fall again (they were already -2.4% QoQ in constant currency) or if guidance turns more negative than the current -1.5% to +0.5% range, which would confirm that AI-driven pricing pressure is structurally compressing the labor-arbitrage model rather than cyclically denting it. Watch bookings and the margin line above all else - reported revenue lags both by several quarters.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Vista Energy (VIST) Q2 2026 — Vista Energy (VIST) reported Q2 2026 (Jul 16): total revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY) at a 70% margin; production 156,061 boe/d (+32% YoY, ~87% oil), oil 135,427 bbl/d (+33%); realized oil $89.4/bbl (+44% YoY) at a $4.5/boe lifting cost. Reported EPS was $3.0 (+37% YoY, flattered by an acquisition gain), but ADJUSTED EPS of $2.38 MISSED the ~$3.15 consensus - the shortfall was below-the-line, as D,D&A jumped 53% to $271M and taxes doubled while Vista consolidated the Equinor (Bandurria Sur / Bajo del Toro) assets acquired in May. Capex $467M; free cash flow $491M ex-acquisition. Net debt $3.06B; net leverage 1.41x (1.25x pro forma), targeting ~1.0x by year-end. Guidance: ~158k boe/d for 2026 (Q4 ramping toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/- ~$200M per $10/bbl). The stock is ~$64, about 21% below its $81 high. Our EV/EBITDA work (4x 2026E EBITDA, with a deliberate Argentina discount) lands fair value ~$80. Wall Street: unanimous Buy (6/0/0), ~$85 average target. Our call: BUY, 3/5.

Vista Energy is an Argentine oil producer and essentially a pure-play on Vaca Muerta - one of the best shale basins outside the U.S. In Q2 2026 the headline looked like a miss: adjusted EPS of $2.38 landed well short of the ~$3.15 consensus, and yet the operational quarter was a blowout - production up 32% to 156,061 boe/d, revenue up 89%, and adjusted EBITDA up 99% to $805M at a 70% margin. The 'miss' was below the line: reported EPS was actually $3.0 (up 37%, helped by an acquisition gain), but adjusted earnings were dragged by a 53% jump in depreciation (to $271M) and a doubling of taxes as Vista consolidated the Equinor assets (Bandurria Sur and Bajo del Toro) it acquired in May - the accounting cost of scaling up, not a crack in the business. Vista realized $89.40/bbl for its oil at a $4.50/boe lifting cost (one of the lowest anywhere), exports about two-thirds of its crude for hard currency, and generated $491M of free cash flow ex-acquisition. The deal did push net debt to $3.06B and leverage to 1.41x (1.25x pro forma), with management targeting ~1.0x by year-end. 2026 guidance: ~158k boe/d (Q4 toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent. On EV/EBITDA - the right lens for a commodity producer - Vista trades at barely ~3x this year's EBITDA; at 4x, with a deliberate Argentina discount, fair value is ~$80 vs ~$64 today. Wall Street is a unanimous Buy (6/0/0) with a ~$85 target. Our call: BUY, 3/5 - a cheap, fast-growing, low-cost oil producer, priced for an Argentina risk (FX, export duties, capital controls) that may be overdone but is genuinely un-hedgeable. Not financial advice.

THE CALL: BUY (3/5, A CHEAP, FAST-GROWING, LOW-COST VACA MUERTA OIL PRODUCER, PRICED FOR ARGENTINA RISK THAT MAY BE OVERDONE) — base-case value ~$80 vs ~$64 today.

KEY METRICS:

- Revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY), 70% margin

- Production 156,061 boe/d (+32% YoY, ~87% oil); oil 135,427 bbl/d (+33%)

- Realized oil $89.4/bbl (+44% YoY); lifting cost $4.5/boe (world-class low)

- Reported EPS $3.0 (+37%, acquisition gain); ADJUSTED EPS $2.38 vs ~$3.15 est (MISS) - D,D&A +53% to $271M, taxes doubled

- Capex $467M; free cash flow $491M ex-acquisition; net debt $3.06B; leverage 1.41x (1.25x pro forma) -> ~1.0x target

- Equinor deal (Bandurria Sur 25.1% + Bajo del Toro 35%) consolidated from May 1, 2026

- FY2026 guide: ~158k boe/d (Q4 ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/-$200M per $10/bbl)

- Our EV/EBITDA fair value ~$80 vs ~$64; Wall Street unanimous Buy (6/0/0), ~$85 avg target

What to watch: Bullish confirmation: production ramping toward ~170k boe/d in Q4, net leverage falling back toward ~1.0x on free cash flow, and Brent holding near $85 - each would support a re-rating from ~3x toward peer multiples. The thesis breaks on an oil-price sell-off (every $10/bbl of Brent is ~$200M of second-half EBITDA) or an Argentine shock - peso devaluation, harsher export duties, or capital controls. Watch two dials above all: the Brent oil price and the net-leverage line.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.